Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Chest Imaging, Breath, and Biomarkers in a Screening Trial

17. maj 2017 opdateret af: Moulay Meziane, MD, The Cleveland Clinic

A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial

The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Studieoversigt

Status

Afsluttet

Betingelser

Detaljeret beskrivelse

The fight against lung cancer is waged on three major fronts: prevention, detection and treatment. Our goal is to determine if chest x-rays,computer aided detection (CAD)and a CT scan can detect disease earlier when treatment is more effective. If we improve the detection of disease, we will see if screening reduces the incidence of symptomatic advanced lung cancer relative to no screening in people at high risk to develop lung cancer.

Undersøgelsestype

Observationel

Tilmelding (Faktiske)

1424

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

    • Ohio
      • Cleveland, Ohio, Forenede Stater, 44195
        • Cleveland Clinic

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

40 år til 75 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

Primary care physicians or any other physician may refer potential candidates. Additionally, subjects may see marketing materials and contact the research team directly. There is no restriction to the area of residence of subjects.

Beskrivelse

Inclusion Criteria:

  • ages 40-75 years
  • If ages 40-59, then one of the following criteria needs to be met:

    • Current or ex-smoker with >25 pack years and a family history of lung cancer(parent or sibling) OR
    • current or ex-smoker with > 25 pack years and COPD OR
    • current or ex-smoker with a > 35 pack year history
  • If ages 60-75, then one of the following additional criteria needs to be met:

    • Current or ex-smoker with >25 pack years and a family history of lung cancer (parent or sibling) OR
    • Current or ex-smoker with >25 pack years and COPD OR
    • Current or ex-smoker with a >30 pack year history
  • Subject is able to return to Cleveland Clinic for annual follow-up screening
  • Subject is willing to sign a medical release form

Exclusion Criteria:

  • Current health requires oxygen
  • Have had a chest x-ray or CT of the chest within the last 6 months
  • Previous pneumonectomy
  • Lobectomy of the lung within the last 5 years
  • Diagnosed malignancy within the last 5 years, excluding non-melanoma skin cancer, carcinoma in situ of the cervix and localized prostate cancer
  • A medical condition that would prevent treatment for lung cancer
  • Within the last 6 weeks, one of the following has occured:

    • A new cough or chronic cough that has gotten worse
    • Either new shortness of breath, or any worsening of shortness of breath
    • A cough producing blood
    • Constant chest pain
    • Respiratory infection, pneumonia, or cold
    • Unintentional and unexplained weight loss greater than 5% of total body weight

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
all enrolled subjects
Intervention is chest x-ray and CT scan. The chest x-ray image is read first without computer aided detection (CAD) and then a second time with computer aided detection (CAD) the CT scan is read by one reader. Subjects are asked to contribute breath and blood samples.
PA view, low dose CT scan
Andre navne:
  • CAD
  • computer aided detection

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
The sensitivities of chest x-ray with CAD and chest CT
Tidsramme: One year after scan
The false positive rates of chest x-ray with CAD and chest CT will be compared. The analysis will be based on the study subjects from this prospective study who test positive with chest x-ray and/or CT and who are determined not to have lung cancer during the follow-up period.
One year after scan

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Disease-specific mortality between screening with chest x-ray and CAD versus no screening
Tidsramme: One year after scan
Mortality rate in screening x-ray vs CAD
One year after scan
All-cause mortality rate between screening with chest x-ray and CAD versus no screening
Tidsramme: One year after scan
All cause mortality rate
One year after scan
Length of time between randomization and the incidence of symptomatic advanced lung cancer for screened subjects versus controls
Tidsramme: One year after scan
Time between randomization and symptom
One year after scan
Does lung cancer screening with chest x-rays and computer aided detection (CAD) reduce the incidence of symptomatic advanced lung cancer in a high risk population
Tidsramme: One year after scan
Cancer detection rate between chest x-ray and CAD
One year after scan
The quality of life between screening with chest x-ray and CAD versus no screening.
Tidsramme: One year after scan
Quality of life between the chest x-ray group and the CAD group
One year after scan

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Studiestol: Micheal Phillips, M.D., The Cleveland Clinic
  • Ledende efterforsker: Moulay Meziane, MD, Chair of Thoracic Imaging

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. september 2008

Primær færdiggørelse (Faktiske)

1. maj 2014

Studieafslutning (Faktiske)

1. maj 2014

Datoer for studieregistrering

Først indsendt

10. november 2008

Først indsendt, der opfyldte QC-kriterier

9. august 2012

Først opslået (Skøn)

13. august 2012

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

18. maj 2017

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. maj 2017

Sidst verificeret

1. maj 2017

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 07-455
  • State of Ohio grant (Andet bevillings-/finansieringsnummer: 06-055)
  • 06-055 (Andet bevillings-/finansieringsnummer: State of Ohio)

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Lungekræft

3
Abonner